Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
about
Emerging drugs for Guillain-Barré syndromeGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisInterventions for fatigue in peripheral neuropathyIntravenous immunoglobulin for Guillain-Barré syndromeImmunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesPharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromePharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndromePharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndromeInterventions for fatigue in peripheral neuropathyImmunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesIntravenous immunoglobulin for Guillain-Barré syndromeExercise for people with peripheral neuropathyIntravenous immunoglobulin for Guillain-Barré syndromeImmunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathiesHealth-related quality of life in Guillain-Barré syndrome patients: a systematic reviewConnecting impairment, disability, and handicap in immune mediated polyneuropathiesSystematic review: fatigue in inflammatory bowel disease.Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe diseasePrevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation settingCampylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barré syndrome, and reactive arthritist.The long-term functional status in patients with Guillain-Barré syndrome.Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom.Focus on fatigue amongst young adults with spastic cerebral palsy.Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathiesExperienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathyPhysical fitness, fatigue, and quality of life after liver transplantation.Treatment of Guillain-Barré syndrome and CIDP.Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trialFatigue and related factors after liver transplantation.Immunotherapy in Peripheral NeuropathiesGuillain-Barré syndrome and its treatment.Parkinson's disease and fatigue.Measuring fatigue in persons with spinal cord injury.Neuropsychological/-psychiatric deficits in immune-mediated neuropathies.Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson's disease patients.Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials.Health status in non-dystrophic myotonias: close relation with pain and fatigue.
P2860
Q22241376-FAD361FA-F8BE-4ADF-9AD1-A5AF688D9190Q22251013-E549F679-9D2C-4EFE-BDBC-6A9ADC42B4F7Q24187233-0C618B97-64D5-43D7-94AF-1A608888169BQ24193522-06DB753A-6186-4FDB-8BDE-D636B79B338FQ24197877-655DCCC7-5B02-4F22-A828-4DA23F51B2D8Q24200916-CBC29497-7C35-4151-A5FE-6C37D1DACC56Q24202100-33A3B0F2-563E-4B15-AA0E-7836DF85FE6BQ24234992-F7974EFE-D66E-4C39-A2A4-B175ACEA2221Q24235600-E72F8ECF-B633-4579-92F3-A117C8D08F97Q24236680-455C001F-9998-47B4-AD5C-64C71BC5E054Q24240807-62857B67-F39F-47D9-8D7C-9A9FE8F298BFQ24243918-1A73CEDA-553F-4FDA-A978-95C7ED3FE311Q24244575-A1154FEB-E0F5-43DC-99BC-6A4C5D0CD906Q24246017-56E79CCC-C8F2-47DC-A8C3-7118614590C8Q24247429-9C9821E5-584C-4D1A-9936-81193CEF9122Q24250235-6A62A4F0-088A-42E8-AAA1-E763BD207265Q28306474-939BC442-0089-4505-A2FC-2BFBDD16C80EQ33185473-42DA2B9C-FEF5-453E-9B35-ADB758C89327Q33574005-9CAAC6A1-52B3-4CF3-89BF-D6AFC68FA46AQ33666033-F47B1E43-DC18-4A5C-90B9-40A3FED5C8BDQ34169899-C4D39FA2-9FD6-4A8C-973B-B636D488169AQ34600024-561026C6-5449-4313-BC59-767928069771Q34601228-8B857118-FA19-4105-BCDE-21FD2A327113Q34686078-02CCE588-857D-4CCD-A6C7-E6E0DC57762EQ34761939-06A6D216-0EDD-4614-AE2B-A047A59948A0Q35467350-A77D9490-B53A-4EF1-B4E1-9EB63CDE8DACQ35484335-2419BBD4-0DB4-4BB3-AA53-C89139C5205DQ35751804-65576AA9-47B0-46D3-82F4-2E9CA17FFA73Q35880773-4DEDEBE1-2F97-4817-A532-BD354663832DQ36164126-5FF5293D-76D5-4E92-A4B4-1AC5CF02FA14Q36226213-A7DFCAE9-67EF-41AA-89E8-53714471DF2CQ36383860-E6BF6115-DE05-4EC7-A32B-25DBFB1D2944Q36484418-8A5AACE7-3FD5-4461-932A-E9F0428B6130Q36641540-6D4A0405-9BD2-4AD9-83B2-AD48C035FF32Q36666578-12F84F60-7BC0-4838-865B-02DC2351FA3AQ36677684-172A69FD-6143-4592-9E40-EFA286AC663FQ36822115-8DC4FCFA-B5FA-4CB0-8BD3-BD83EE7E8707Q37191452-F2B719B4-F75D-4323-9D21-9708F964F679Q37207302-FA5D932E-A70E-4B89-A33C-2D2A22A9B2F1Q37233918-188793C2-03D3-466B-8412-9975F2580891
P2860
Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Fatigue in immune-mediated pol ...... e and Treatment (INCAT) Group.
@en
Fatigue in immune-mediated pol ...... Neuropathy Cause and Treatment
@nl
type
label
Fatigue in immune-mediated pol ...... e and Treatment (INCAT) Group.
@en
Fatigue in immune-mediated pol ...... Neuropathy Cause and Treatment
@nl
prefLabel
Fatigue in immune-mediated pol ...... e and Treatment (INCAT) Group.
@en
Fatigue in immune-mediated pol ...... Neuropathy Cause and Treatment
@nl
P2093
P356
P1433
P1476
Fatigue in immune-mediated pol ...... e and Treatment (INCAT) Group.
@en
P2093
Merkies IS
Schmitz PI
van Doorn PA
P304
P356
10.1212/WNL.53.8.1648
P407
P577
1999-11-01T00:00:00Z